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Summary Twenty-six patients with treated breast cancer who had been randomised previously to receive
combination chemotherapy including alkylating agents (n = 14) or to undergo oophorectomy (n = 12) follow-
ing surgery underwent cytological and colposcopic screening of the uterine cervix. Colposcopically directed
cervical punch biopsies were taken from all patients in whom a colposcopic abnormality was detected. Breast
cancer patients were compared with 79 controls with normal cervical cytology and no known breast
malignancy. Colposcopically directed punch biopsies were taken from the cervical transformation zone of all
controls. Significantly more breast cancer patients who had received chemotherapy (43%) than controls (10%)
had CIN (P<0.01) and significantly more patients who had received chemotherapy (14%) than controls (3%)
had CIN 2 or 3 (P<0.05).
The proportion of breast cancer patients in the oophorectomy group with CIN (17%) did not differ
significantly from the control group. No case of CIN was detected by cervical cytology. This study suggests
that breast cancer patients receiving combination chemotherapy including alkylating agents are at increased
risk of CIN, and that cervical cytology alone may be an inadequate form of screening for these patients.
We have reported previously that female patients with Hodg-
kin's disease are at increased risk of cervical intraepithelial
neoplasia (CIN) (Hughes et al., 1989). Patients treated with
combination chemotherapy were found to be at particular
risk of CIN and we commented that it was difficult to
determine whether the increased risk was due to the underly-
ing disease process or to the chemotherapeutic agents used.
These drugs include alkylating agents which are mutagenic
and carcinogenic in laboratory systems and are also
immunosuppressive (Schilsky & Erlichman, 1982). It is well
recognised that lymphoma patients are at increased risk of
second malignancies (Tester et al., 1984) and some authors
have postulated that this increase is related to the use of
these chemotherapeutic agents (Anon, 1985). The present
study was performed in an attempt to separate the effects of
chemotherapy from the effects of an underlying haemato-
logical disturbance on the development of CIN. We studied a
well-defined group of patients with surgically treated breast
cancer, who had received adjuvant combination chemo-
therapy or undergone oophorectomy as part of a randomised
study. Breast cancer patients are known to be at increased
risk of second malignancies especially of the contralateral
breast, the ovary, endometrium and large bowel (Schoenberg
et al., 1969). Their risk of cervical carcinoma is not generally
thought to be increased, however, (Adami et al., 1984), and
in terms of reproductive history and socio-economic status
the two malignancies have very different risk factors
(McMahon et al., 1973; Kelsey & Hildreth, 1983; La Vecchia,
1985) so that one might predict that breast cancer patients
should be at lower than average risk ofcervical neoplasia. By
comparing the prevalence of CIN in patients who had
received combination chemotherapy (including alkylating
agents) and in breast cancer patients who were otherwise
similar but had not received chemotherapy, with the pre-
valence of CIN in a group of normal controls, we hoped to
explore further the question of the role of chemotherapeutic
agents in the aetiology of cervical neoplasia.
Patients and methods
A group of 58 patients attending the Breast Clinic at Long-
more Hospital, Edinburgh, was invited to participate in the
present study. All had treated breast cancer which was in
remission at the time of entry to the study. The patients
studied were already participants in a randomised study of
premenopausal women with operable breast cancer clinical
stage (T 1, 2, 3; N 0, 1; M 0), with histologically proven
axillary node involvement. They had been randomised to
receive adjuvant chemotherapy or oophorectomy plus or
minus prednisolone and had received this treatment soon
after breast surgery.
The chemotherapy consisted of cyclophosphamide 750 mg
m 2, methotrexate 50 mgm-2 and 5-fluorouracil 600 mgm-2
given by intravenous bolus injection at 21 day intervals for
eight courses. The drugs were delayed for 1 week if white
blood count was less than 3 x I091' or the platelet count
less than 100 x 1091' and the dose of each drug administer-
ed was reduced by 75% of the stated dose if drug delay due
to marrow toxicity had occurred in two consecutive courses.
Prednisolone was given as a daily dose of 7.5 mg for 5
years.
The oophorectomy was performed surgically as a salpingo-
oophorectomy. All patients were rendered amenorrhoeic after
the procedure.
Twenty-six of the 58 agreed to take part in the Colposcopy
Clinic study. All had been sexually active in the past or at
present, and were between the ages of 40 and 61. Sixteen did
not wish to participate and 16 were excluded for other
reasons, four had undergone total abdominal hysterectomy,
one being disabled and 11 living out of Edinburgh.
The mean length of time between breast surgery and atten-
dance at the Colposcopy Clinic was 72 months (range
34-107) for the patiets who had received chemotherapy and
76 months (42-129) for the patients who underwent
oophorectomy. Breast cancer patients were compared with 79
normal controls who have been described previously (Hughes
et al., 1989). No control patients gave a history of breast
malignancy. A full reproductive, sexual, contraceptive, smok-
ing, gynaecological and cervical smear history was taken
from all patients and controls. If patients reported having
had previous cervical smears, these were traced if possible
and reviewed by M.C. Cervical smears were taken from all
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patients by R.H. or G.S. as described previously (Hughes et
al., 1989).
Patients and controls underwent full colposcopic examina-
tion by R.H., M.A. or G.S. Cervical punch biopsies were
taken from patients only if a colposcopic abnormality was
visualised and from all controls, and were fixed immediately
in Bouin's solution for routine histopathological assessment.
Cervical intraepithelial neoplasia (CIN) was graded according
to recognised criteria (Buckley et al., 1982) and koilocytosis
(Meisels & Fortin, 1976) was reported if present.
Results
Generalpatient data
It can be seen from Table I that the breast cancer patients
studied were significantly older (P<0.01) by Mann-Whitney
U-test) and reported a later onset of sexual activity and fewer
sexual partners than the control patients with normal cervical
cytology. The breast cancer patients and controls were
matched for parity. Fewer of the breast cancer patients
smoked.
Previous cervical cytology
All 26 breast cancer patients reported having had completely
normal cervical cytology in the past. Smears from 18 of these
patients could be traced and were confirmed as being normal.
The mean length of time since the last normal smear for the
whole group was 63.8 months (range 18-96) and for the
patients with CIN, 56.2 months (range 11-84).
Cervical histology
It can be seen from Table II that eight (30.8%) breast cancer
patients had CIN, compared with eight (10.1%) controls.
This difference is statistically significant (P<0.02) by the x2
test. Six breast cancer patients had CIN 1, one had CIN 2
and one had CIN 3. Both the patients with CIN 2 or CIN 3
had received chemotherapy. Six control patients had CIN 1
and two had CIN 2. When breast cancer patients who had
received combination chemotherapy are considered spearately
from those who underwent oophorectomy, it can be seen
from Table II that significantly more 'chemotherapy' patients
than controls had CIN (P<0.01) but that this is not true for
the oophorectomy patients (P>0.1). Significantly more
'chemotherapy' patients than controls had CIN 2 or 3 (2 of
14 vs 2 of 79, x2 = 3.99, P<0.05). The percentage of breast
cancer patients with koilocytosis alone is not significantly
different from the percentage of control patients with this
abnormality. Table III shows that the breast cancer patients
with CIN were very similar to the breast cancer patients in
whom no significant cervical abnormality was detected in
terms of age, sexual history and parity. More breast cancer
patients with CIN smoked than did those in whom no abnor-
mality was detected. Those with CIN had also had their
breast tumours diagnosed for longer than those without CIN.
Neither of these differences is statistically significant by the
Mann-Whitney U-test.
Discussion
We have demonstrated a significantly higher prevalence of
cervical intraepithelial neoplasia (CIN) in patients who
received adjuvant combination chemotherapy for breast
cancer than in a control group of women. Ideally each case
should have been compared with two or three controls,
matched with the case for known risk factors. However,
colposcopic examination and biopsy is an invasive procedure
and, when carried out on patients anaesthetised for minor
gynaecological surgery, significantly increases the duration of
the general anaesthetic. The recruitment and examination of
the much larger number of controls necessary for this app-
roach would have presented considerable practical problems
Table I Patients' characteristics
Mean age of
coitarche (range)
22.2 (16-30)
13 (93) 22.9 (19-30)
11 (92) 21.2 (16-27)
71 (90) 19 (14-27)
Median no. sexual
partners (range)
1 (1-3)
1 (1-3)
1 (1-2)
2 (1-6)
n = number of patients
Table II Cervical histology of patients and controls
Breast cancer Breast cancer
treated by treated with All breast cancer
Cervical histology Controls oophorectomy chemotherapy patients
(n= 79) (%) (n= 12) (%) (n= 14) (%) (n=26) (%)
No significant 57 (72) 8 (67) 8 (57) 16 (62)
abnormality
Koilocytosis only 14 (18) 2 (17)NS 0 ( )NS 2 ( 8)NS
CIN 8 (10) 2 (17)NS 6 (43)a 8 (31)b
aX' = 9.15 P<0.0 ('chemotherapy' breast cancer patients vs controls). bX2 = 6.45 P<0.02 (all breast cancer
patients vs controls).
Number
parous (%)
24 (92) All breast
cancer
patients
(n = 26)
Breast cancer
patients
treated with
chemotherapy
(n= 14)
Breast cancer
patients
treated by
oophorectomy
(n = 12)
Control
patients
(n = 79)
Mean age
(range)
52.5
(40-61)
53.1
(40-61)
51.5
(42-61)
39
(20-71)
Current
smokers (%)
7 (27)
3 (21)
4 (33)
37 (47)1084 R.G. HUGHES et al.
Table III Breast cancer patients' characteristics (grouped according to cervical histology)
Mean age at Median number Current Months since
Mean age Numberparous coitarche sexualpartners smokers diagnosis
(range) (%) (range) (range) (%) (mean range)
No significant 51.6 14 (88) 21.8 1 (1-3) 3 (19) 67 (34-106)
abnormality (40-59) (16-26)
(n = 16)
Koilocytosis 55.5 2 (100) 24 1(1) 1(50) 106 (83-129)
alone (50-61) (21-27)
(n = 2)
CIN 53.5 8 (100) 22.4 1 (1-2) 3 (38) 80 (45-107)
(n= 8) (45-61) (18-30)
and it was therefore decided that it wasjustifiable to compare
breast cancer patients with available controls. In fact the
control patients reported on average more sexual partners
and an earlier coitarche and were more likely to smoke than
the breast cancer patients (see Table I). A higher prevalence
of CIN in the controls than in the breast cancer patients
would be predicted on the basis of these known risk factors
(La Vecchia, 1985; Winkelstein et al., 1984). However, the
reverse was found, that is a significantly higher prevalence of
CIN in breast cancer patients (especially those treated with
combination chemotherapy) than in controls. The breast
cancer patients were significantly older than the control
patients, and so might be expected to be at slightly higher
risk of CIN. We feel that is very unlikely that the difference
in age accounts for the significant difference in prevalence of
CIN between the two groups, especially in view of the fact
that the breast cancer patients are, on epidemiological
grounds, a low risk group.
Breast cancer patients are well recognised to be at in-
creased risk of second malignancies including carcinoma of
the other breast, the endometrium, ovary and large bowel
(Schoenberg et al., 1969). An increased risk of cervical car-
cinoma has not, however, been demonstrated by retrospective
population studies (Schoenberg et al., 1969; Schottenfelt &
Berg, 1971; Adami et al., 1984), except by one group
(Schwartz et al., 1989) who found an increased risk of cer-
vical cancer in Detroit breast cancer patients (Standardised
incidence ratio = 1.54). Mortality data, on the other hand,
suggest a negative correlation between breast cancer and
cancer of the cervix (Blot et al., 1977). Late age at first birth
and nulliparity are recognised risk factors for breast cancer
(MacMahon et al., 1973; Kelsey & Hildreth, 1983), while
early coitarche is a known risk factor for cervical carcinoma
(La Vecchia, 1985) so that on epidemiological grounds one
would not anticipate an increased risk of cervical carcinoma
in breast cancer patients.
The results of the present study clearly demonstrate an
increased prevalence of CIN in breast cancer patients and
especially in those treated with combination chemotherapy in
contrast with the studies quoted above. It should be noted
that we identified patients with pre-invasive cervical lesions,
rather than invasive cancer. It will be necessary to perform
large population based studies analysing breast cancer
patients treated with combination chemotherapy separately
from those who have not received this treatment in order to
determine whether the observed increase in prevalence of
CIN is reflected in an increase in risk of invasive cervical
cancer in patients treated with chemotherapeutic agents. It is
possible that the increased risk of cervical carcinoma in
breast cancer patients described by Schwartz et al. (1989) is
related to an increased use of adjuvant chemotherapy for
these patients in recent years, in contrast with the earlier
studies (Schoenberg et al., 1969; Schottenfeld & Berg, 1971;
Blot et al., 1977; Adami et al., 1984). The breast cancer
patients described in the present study had been randomly
allocated to receive adjuvant combination chemotherapy or
to undergo oophorectomy and were matched for breast
cancer stage and for length of time since breast surgery.
There is therefore no reason to suppose that the patients who
had received chemotherapy should have any other reason to
be at increased risk of CIN. This is not the case for the
lymphoma patients described in our earlier study (Hughes et
al., 1989). The lymphoma patients who had received
chemotherapy tended to have more extensive disease than
those treated with radiotherapy so that it was difficult to
separate the effects ofchemotherapy from those ofthe under-
lying disease. We believe that the results of the present study
provide further evidence to support our contention that com-
bination chemotherapeutic regimes which include alkylating
agents increase the risk of subsequent cervical neoplasia.
None of the cases of CIN in breast cancer patients was
detected by cervical cytology, although the smears were taken
under optimal conditions at colposcopy. This is a worrying
finding but is consistent with our previous data (Hughes et
al., 1989; Hughes et al., 1992) and with that of other authors
(Richart & Barron, 1981; Giles et al., 1988). Giles et al.
(1988) report a cytological false negative rate of 58% for
small lesions of CIN 1 and CIN 2 and postulate that this is
due to the failure of these smaller lesions to exfoliate
sufficient abnormal cells to enable accurate detection by
cytology. The finding of a significant false negative rate adds
further strength to our previous recommendation that
patients considered to be at increased risk of CIN should be
screened using colposcopy in addition to cervical cytology.
We are grateful to the administrative and nursing staff of the
Lothian Area Colposcopy Clinic for their kind assistance.
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